US-China Economic and Trade Arrangement (Busan Summit) — one-year mutual suspension of reciprocal tariff escalation, China rare-earth/critical-minerals export controls, and US affiliates rule; soybean and agricultural purchase commitments

Mechanism

The arrangement operates through three reinforcing instruments rather than a single binding treaty:

1. US executive-order freeze — the 4 November 2025 EO modifies the country-specific reciprocal-tariff rate on PRC-origin goods imposed under IEEPA and the April 2025 reciprocal-tariff regime (already filed: 2025-04-02-us-trump-reciprocal-tariff-regime). The "additional ad valorem rate of duty" is set at 10% — well below the 24% rate that would otherwise have re-engaged after the May 2025 and August 2025 interim suspensions expired. The suspension runs for one year from 10 November 2025 through 10 November 2026.

2. Linked PRC concessions — published mainly via MOFCOM announcements 8–9 November 2025: a one-year suspension of the October 2025 extraterritorial rare-earth-and-critical-minerals export-control package; suspension of retaliatory agricultural tariffs through 31 December 2026; closure of MOFCOM antitrust / unreliable-entity reviews against named US chip and chip-equipment firms. These do not repeal the underlying export-control list (Decree 2025 No. 61 / 9 October 2025) — they pause enforcement.

3. Quantified non-tariff commitments — soybean off-take of ≥25 MMT/year in 2026-2028 (vs. recent run-rate of ~22 MMT and 2018-Phase-One target of ~32 MMT), resumption of sorghum and log imports, and reciprocal pauses on Section 301 maritime / shipbuilding measures and BIS extension-of-entity-list-controls to Chinese subsidiaries.

The 10% reciprocal-tariff rate logged in tariff_rate_pct is the delta added to MFN; with prior IEEPA-fentanyl and Section 301 stacks still in force, the effective rate on most Chinese imports remains in the 30-60% range depending on HTSUS line.

Downstream implications

• MacroLens China composite — material upward revision: removes

the worst-case "Q4 escalation to 34% reciprocal" scenario from forward-tariff drag on MCHI / FXI / KWEB. Severity 5 set on the scope, not the directional sign — this is a macro-regime event even though near-term price impact is risk-positive for China beta.

• REMX / rare-earth ETFs — paradoxical setup: pause on China

export controls is bearish for non-China REE producers (MP, LYC) in the short term as supply normalises; medium term the "suspension not repeal" framing keeps ex-China capacity premia intact.

• US semiconductor names — NVDA, INTC, QCOM, AMD see immediate

relief on China-revenue line-items; LRCX, AMAT, KLAC benefit from closure of MOFCOM probes. SMH / SOXX positive.

• Soybean / ag complex — SOYB and US ag majors (ADM, BG) get a

visible demand floor; effect partly offset by Brazil-Argentina competitive-pricing response.

• One-year sunset is the binding constraint — the deal is

legally a freeze, not a settlement. November 2026 expiry creates a hard re-negotiation deadline that will dominate H2 2026 macro-tariff scenario analysis.

Open questions

• Does the State Council Tariff Commission publish a formal

reciprocal HS-line schedule for the suspended retaliatory tariffs, or is the 31 December 2026 sunset implemented via rolling renewal of the existing waiver list?

• Does USTR formally extend the Section 301 maritime / shipbuilding

countermeasures pause (already filed: 2025-04-17-us-section-301-china-maritime-logistics-shipbuilding) via a separate Federal Register notice, or does the EO carry that weight?

• Quarterly review mechanism — fact sheet references "regular

reviews" without naming a specific bilateral commission. Watch for designation of US-side (Treasury / USTR) and PRC-side (NDRC / MOFCOM) co-chairs.

• Soybean compliance tracking — Phase One precedent (2020) saw

significant under-delivery; need to file an amendment if 2026 cumulative purchases run materially below the 25 MMT pace.